Science & Technology
Science and Technology
Science and Technology
Mon, February 9, 2009
Vemics iMedicor" ClearLobby to Integrate with NaviNet to Connect Physicians to Pharmaceutical Information and Education
NANUET, N.Y.--([ BUSINESS WIRE ])--Vemics, Inc. (OTCBB: VMCI) today announced a partnership to integrate its iMedicor™ ClearLobby pharmaceutical communications application with the NaviNet® real-time healthcare communications platform from NaviMedix. The partnership will provide a secure link to more than 700,000 physicians in the NaviNet Provider Network, enabling easier online communications and enhanced educational opportunities on key medications and drug therapies. The integration will facilitate a more connected healthcare community by linking key stakeholders – including physicians, hospitals, health insurance providers and pharmaceutical companies – a critical factor in improving the quality of care throughout the entire healthcare continuum.
With this agreement, all healthcare providers using NaviNet will have a direct connection to pharmaceutical information through ClearLobby, providing them with the ability to access critical information on medications and drug developments, including timely product-specific educational resources, peer-reviewed journals, white papers, clinical research studies, webinars and audio programs. Physicians will also have "24/7" access to pharmaceutical representatives for live inquiries, and can order product samples or request a consultation, all in an easy-to-use, web-based service.
"The value that NaviNet brings to physicians is the ability to connect to other key stakeholders in the healthcare delivery process," said Michael Hodgkins, M.D., Chief Medical Officer for NaviMedix. "We're excited to offer our physician and clinician users the ability to interact with a new audience and access medication information to help them deliver optimum care to their patients."
"Pharmaceutical and medical supply companies are challenged to find ways to better communicate with physicians and healthcare providers, constrained by smaller sales forces and tighter physician schedules," said Fred Zolla, CEO, Vemics. "By connecting ClearLobby and NaviNet, we have eliminated several of these barriers and provided a secure, cost-effective way for these audiences to communicate."
About Vemics
Vemics portals combine proprietary and licensed technology platforms with industry specific content, consulting expertise and deep customer support enabling organizations large and small to work, collaborate and learn, online, from anywhere in the world.. Vemics uses its proprietary technology platforms to market, create and deliver the highest quality CME (Continuing Medical Education) programs sponsored by medical societies, pharmaceutical companies, medical device companies and the US Military. iMedicor, the primary Vemics service, allows doctors, administrators and other qualified healthcare workers to send and receive HIPAA-compliant digital medical records, files and images, placing the full resource of the Internet at the disposal of the medical profession. iMedicor also allows various EMR (Electronic Medical Record) systems to communicate, collaborate and exchange records in real time. iMedicor is based in Nanuet, New York. [ www.vemics.com ], [ www.iMedicor.com ].
About NaviMedix
NaviMedix is the national leader in real-time healthcare communications, with a network of 700,000 enrolled providers in all 50 states using its solutions and services. NaviNet®, the company's sophisticated Web-based communications solution, allows providers to interact with the country's leading health plans, including four of the six largest payers, and other sponsoring healthcare service organizations. NaviNet enables sponsors to reach a national network of providers who tap into the solution frequently for medical and business interactions. NaviMedix solutions deliver relevant information from multiple sources into the provider office to support financial, clinical and administrative decision-making and drive more effective physician engagement. For more information, please visit [ www.navimedix.com ] or call us at 617-715-6000 or 800-805-7569.
This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, integration of NuScribe's business into ours, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, as well as statements that include words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements. All forward-looking statements involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. Factors that may cause actual results to differ materially from those in the forward-looking statements include those set forth in our filings with [ www.pinksheets.com ]. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.
